ARTICLE | Company News
Eastbourne proposes Amylin board nominees
February 3, 2009 2:19 AM UTC
Eastbourne Capital Management said it plans to nominate a slate of five directors for election to the 12-member board of diabetes company Amylin (NASDAQ:AMLN). Eastbourne's proposed nominees are: M. K...